Start

Risk Factors for Bleeding During Antithrombotic Therapy from the NICE Guidelines for Atrial Fibrillation

Purpose:

To identify risk factors for bleeding in a patient taking oral anticoagulant therapy for atrial fibrillation based on the NICE guidelines.

Specialty:

Cardiovascular Diseases, Vascular Medicine, Clinical Pharmacology, Pharmaceutical Medicine

Objective:

risk factors, severity, prognosis, stage

ICD-10:

I48

Description:

The risk for bleeding during antithrombotic therapy for atrial fibrillation can be determined based on a number of clinical factors identified by the NCCCC as funded by NICE in the United Kingdom.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone